Belgium· BE-AMP-SAM661433-00

Axhidroks 8 mg/g

A glycopyrronium product containing glycopyrronium bromide, registered in Belgium by Dr. Wolff Arzneimittel. The same ATC class is registered in 14 of our 19 countries.

ATC D11AA01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about glycopyrronium bromideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Glycopyrronium is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AA01 (glycopyrronium), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search glycopyrronium products by name

Glycopyrronium · ATC D11AA01

14 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Glycopyrronium Bromide
Manufacturer: Dr. Wolff Arzneimittel
Country: Belgium (BE)
ATC code: D11AA01
ATC class: Glycopyrronium
Defined daily dose: 8.8 mg, T
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 1

be_apb
4803615

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

108 interactions on record for glycopyrronium.

Graded by severity as the source publishes them — 107 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check glycopyrronium against other medicines How interaction checks work

Glycopyrronium · interactions on record

108 records

107 moderate
1 minor

Most severe, free to view

DicycloverineA03AA07moderate
PropanthelineA03AB05moderate
MepenzolateA03AB12moderate
TrospiumA03AB20moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glycopyrronium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycopyrronium products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Axhidrox, Glycopyrroniumbromid Accord
Bulgaria · Axhidrox, Амидил Амихалер
Cyprus · Glycopyrronium Bromide Accord, Robinul
Czechia · Amidil Amihaler, Axhidrox
Germany · Axhidrox, Glycopyrronium Axiromed
Denmark · Axhidrox, Glycopirronium Medical Valley
Estonia · Axhidrox
Finland · Axhidrox, Glykopyrroniumbromidi Accord
France · Glycopyrronium Biogaran, Glycopyrronium Wolff
United Kingdom (Northern Ireland) · Assicco, Glycopyrrolate Mercury Pharmaceuticals
Greece · Axhidrox, Glycopyrronium Verisfield
Croatia · Axhidrox
Hungary · Axhidrox, Rybrila
Ireland · Axhidrox, Glycopyrronium Bromide Ethypharm
Iceland · Seebri Breezhaler, Sialanar
Italy · Axhidrox, Glicopirronio Bromuro Accord
Liechtenstein · Seebri Breezhaler, Sialanar
Lithuania · Akshidroz
Luxembourg · Axhidroks, Robinul
Latvia · Axhidrox
Malta · Glycopyrronium Morningside
Netherlands · Axhidrox, Dusmyla
Norway · Axhidrox, Glycopirronium Medical Valley
Poland · Amidil Amihaler, Axhidrox
Portugal · Glicopirrónio Axidrox
Romania · Axhidrox
Sweden · Axhidrox, Glycopirronium Medical Valley
Slovenia · Axhidrox
Slovakia · Axhidrox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9f95901e-b61c-4039-bbcf-d0f477a6a24b
GET /v1/drugs/9f95901e-b61c-4039-bbcf-d0f477a6a24b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cream",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Axhidroks 8 mg/g",
  "name_fr": "Axhidroks 8 mg/g",
  "name_nl": "Axhidroks 8 mg/g",
  "amp_code": "SAM661433-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "8.0000",
    "8.0000",
    "10.0000",
    "80.0000",
    "30.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Glycopyrronium Bromide",
    "Glycopyrronium",
    "Benzyl Alcohol",
    "Cetostearyl Alcohol",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Glycopyrronium",
  "authorisation_numbers": [
    "BE661433"
  ]
}

API reference MCP server Plans

See everything about glycopyrronium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console